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Abstract
Introduction Polyneuropathy (PN) is a common condition with significant morbidity. We developed tele-polyneuropathy 
(tele-PN) clinics to improve access to neurology and increase guideline-concordant PN care. This article describes the mixed-
methods evaluation of pilot tele-PN clinics at three community sites within the Greater Los Angeles VA Healthcare System.
Methods For the first 25 patients (48 scheduled visits), we recorded the duration of the tele-PN visit and exam; the perfor-
mance on three guideline-concordant care indicators (PN screening labs, opiate reduction, physical therapy for falls); and 
patient-satisfaction scores. We elicited comments about the tele-PN clinic from patients and the clinical team. We combined 
descriptive statistics with qualitative themes to determine the feasibility and acceptability of the tele-PN clinics.
Results The average tele-PN encounter and exam times were 28.5 and 9.1 min, respectively. PN screening lab completion 
increased from 80 to 100%. Opiate freedom improved from 68 to 88%. Physical therapy for patients with recent falls increased 
from 58 to 100%. The tele-PN clinic was preferred for follow-up over in-person clinics in 86% of cases. Convenience was 
paramount to the clinic’s success, saving an average of 231 min per patient in round-trip travel. The medical team’s caring 
and collaborative spirit received high praise. While the clinic’s efficiency was equal or superior to in-person care, the limited 
treatment options for PN and the small clinical exam space are areas for improvement.
Conclusion In this pilot, we were able to efficiently see and examine patients remotely, promote guideline-concordant PN 
care, and provide a high-satisfaction encounter.
Keywords Telemedicine · Teleneurology · Neuropathy · Polyneuropathy · Evidence-based · Guidelines
Introduction
Polyneuropathy (PN) is a common condition that affects 
2–7% of the population [1]. People with PN suffer from 
higher functional impairments (e.g., trouble bathing, house-
keeping) and mortality rates, even after controlling for asso-
ciated comorbidities [2]. Prompt diagnosis and management 
of PN may stop the progression of disease or prevent com-
plications through pharmacologic and safety interventions.
Despite practice parameters and quality measures to 
encourage evidence-based care [3, 4], the diagnosis and 
management of PN vary widely in the community. For 
example, Callaghan et al. noted over 400 patterns of test-
ing for PN from 15 relevant tests [5]. Of concern was the 
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frequency of ordering high-cost magnetic resonance imag-
ing, which has a limited role in the evaluation of PN, and 
the infrequency of ordering low-cost, high-yield laboratory 
tests [i.e., a diabetes test, vitamin B12 levels, and serum pro-
tein electrophoresis with immunofixation (SPEP with IFE)] 
[5]. Providing access to neurologists appears to improve the 
delivery of evidence-based PN care [6].
Unfortunately, due to geographic or transportation barri-
ers, as well as the paucity of neurologists in rural areas, an 
in-person neurological visit is not always feasible for some 
people with PN [7, 8]. One potential solution is to support 
primary care providers in the practice of evidence-based 
PN care with educational outreach, institutional protocols, 
and/or audit and feedback systems; however, these strate-
gies have demonstrated only a small improvement in prac-
tice [9]. Therefore, we designed a teleneurology clinic for 
PN (i.e., a real time, remote audio–visual communication 
between a patient and a neurologist for PN care) to increase 
access to neurologists compared to in-person only models 
and thus enhance utilization of evidence-based care through 
the experts’ knowledge of current guidelines, translation of 
guidelines into realistic clinical policies, and tailoring of 
clinical policies to individual patients [10, 11].
This article describes the development and the mixed 
quantitative and qualitative evaluation of a pilot teleneurol-
ogy clinic for PN (tele-PN clinic), evaluating its feasibility 
and acceptability within a large healthcare system. Our goals 
were threefold: (1) to determine the ability of the tele-PN 
team to efficiently see and examine patients (2) to increase 
PN guideline-concordant care, and (3) to provide a high-
satisfaction encounter.
Methods
Institutional review
This study was approved as a program evaluation activity by 
the Greater Los Angeles Veterans Affairs (GLA VA) insti-
tutional review board.
Setting
This pilot was conducted in the GLA VA healthcare sys-
tem, the largest integrated healthcare organization within 
the VA. Neurologists are located at 3 of the 11 clinical sites. 
The novel GLA VA tele-PN clinics feature a neuromuscu-
lar specialist (NIJ) at the West Los Angeles VA hub site 
and a licensed vocational nurse telepresenter at the com-
munity-based outpatient center (CBOC) spoke site where 
the patient is visiting. The VA Clinical Video Teleconfer-
ence platform uses a wired network with a bandwidth of 
384 kilobits per second. Telemedicine equipment includes 
Cisco CTS-EX90-K9 (resolution: 640 × 360) at the hub site 
and GlobalMed media carts (resolution: 1920 × 1080) at the 
spoke sites.
Three CBOCs were selected as pilot spoke sites in the 
summer of 2017 based on a needs assessment for PN care 
and their telemedicine capabilities. Primary care providers 
and managers at all three sites were partners in this outreach 
effort, and we co-developed a service agreement for each site 
so that patients meeting criteria for the tele-PN clinic could 
be directly enrolled with patient consent without a referral 
from the patient’s primary care provider.
Patient selection for the tele‑PN clinics
Patients who receive primary care from a spoke site and have 
a PN diagnosis in their active problem list (based on ICD10 
codes of E08.4–E13.4, G60–65, G90 in the electronic medi-
cal record) are screened for the clinic by the clinic nurse or 
study author (AH or AMW, respectively). After chart review, 
patients are excluded from invitation to the tele-PN clinic if 
they meet any of the following three criteria: (1) they do not 
meet Toronto Consensus Panel criteria for polyneuropathy 
(i.e., there were no symptoms, no signs, and no electrodi-
agnostic tests supportive of PN) [12]; (2) they are asymp-
tomatic in terms of pain and mobility on current treatment; 
or (3) they have another complicating neurologic condition 
requiring an in-person neurologic visit (e.g., Parkinson’s dis-
ease). Table 1 summarizes the eligibility screening of patient 
selection for the tele-PN clinics. As of November 1, 2017, 
we had screened a total of 188 patients, 116 (62%) of which 
were deemed eligible for the tele-PN clinics.
Eligible patients are contacted by the study author to 
see if they would be interested in a teleneurology visit for 
PN. This visit is either a new neurology visit or a substitute 
for the in-person visit if the Veteran is already receiving 
Table 1  Eligibility screen for the tele-PN clinics
As of November 1, 2017, there were 100, 119, and 56 patients with 
an active ICD10 diagnosis of polyneuropathy at the three participat-
ing VA clinics for a total of 275 patients. Of those, 188 patients have 
had their medical record screened by the nurse coordinator or study 
investigator. Rows 4–6 list the reason and counts (and percentages) of 
the reviewed patients for exclusion from the tele-PN clinic. The final 
row lists the number (and percentage) of the reviewed patients who 
were deemed eligible for the tele-PN clinic
Count
Total patients with PN diagnosis 275
Patients reviewed/screened 188
 Not PN 27 (14%)
 Asymptomatic 16 (9%)
 Complicated 29 (15%)
Eligible for tele-PN clinic 116 (62%)
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neurologic care. For the pilot, patients who were on multi-
ple neuropathic medications, were having falls, or had been 
lost to neurology follow-up were prioritized to be scheduled 
first per stakeholder request. Stakeholders included the pri-
mary care providers, neurologists, and the tele-PN team. We 
included the first 25 patients as part of the pilot evaluation. 
Patients were scheduled in typical fashion with appointment 
reminders by mailed card and a phone call 3 days prior to 
the visit. Encounters were scheduled for 1 h for new patients 
and 30 min for return visits.
The three tele-PN clinics were established between 
August 2017 and February 2018, and we enrolled 11, 9, 
and 5 unique individuals, respectively, at each site, during 
the pilot phase. Each clinic site runs for 2 consecutive hours 
per month with one teleneurologist and one telepresenter.
Intervention
Tele‑PN clinic encounter description
During the encounter, patients undergo a check-in process, 
vitals, a specialized neuromuscular exam (the VA Neuropa-
thy Scale [VANS]), and the history prior to discussing the 
diagnosis and treatment plan. These discussions are similar 
to those of in-person visits. The VANS (Fig. 1) was devel-
oped by the authors (AMW, NIJ) specifically for the tele-PN 
clinic by modifying existing, validated neuropathy screening 
instruments [13–21]. It has abbreviated balance, gait, reflex, 
and sensory testing that can be observed remotely by the 
neurologist [22].
The study author trained two telepresenters at each site to 
perform the VANS. Training was performed on-site at each 
CBOC for approximately 1 h and consisted of the proper 
Fig. 1  The VA Neuropathy 
Scale
The VA Neuropathy Scale
Romberg
0=normal
1=step off
Left Knee Reflex
0=normal or brisk
1=absent or depressed
Right Knee Reflex
0=normal or brisk
1=absent or depressed
Left Foot Inspection
0=normal
2=ulcers, skin fissures
Right Foot Inspection
0=normal
2=ulcers, skin fissures
Left Toe Vibration
0=normal
1=decreased
2=absent                              Value ________
Right Toe Vibration
0=normal
1=decreased
2=absent                              Value ________
Left Knee Vibration
0=normal
1=decreased
2=absent                              Value ________
Right Knee Vibration
0=normal
1=decreased
2=absent                              Value ________
TOTAL SCORE _____ / 50
Casual Gait
0=normal
1=abnormal
Heel Walk
0=normal
1=abnormal
Tandem Walk
0=normal
1=abnormal
Left Pinprick
0=normal
1=reduced
2=absent
Right Pinprick
0=normal
1=reduced
2=absent
Region8
Region7
Region6
Region5
Region4
Region3
Region2
Region1
7
8
Figure reproduced and modified 
with permission from Wiley© from 
Singleton, et al. JPNS (2008).
Segments for pin sensation reporting
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use of exam tools and exam techniques, a demonstration 
of the full VANS by the neurologist on the telepresenters 
acting as a patient, and several “mock” VANS exams by 
the telepresenters on the neurologist who simulated com-
mon exam situations. VANS exam technique was reinforced 
during clinical encounters. During the on-site training visit, 
room setup and patient flow logistics were also addressed.
Data‑clinic evaluation measures
The following patient-level data were collected by chart 
review or clinical interview for each participant at the time 
of first visit: age, gender, use of durable medical equipment 
(e.g., cane, walker), falls in the last year, suspected PN etiol-
ogy, CBOC location, previous neurology visit for PN within 
or outside the VA, previous PN labs (hemoglobin A1c or 
oral glucose tolerance test, vitamin B12, SPEP with IFE), 
previous nerve conduction study (NCS), previous PN imag-
ing, previous PN medications, and previous referral to physi-
cal therapy for PN-related symptoms. Patient-reported travel 
time difference between local site of VA primary care and 
previous VA neurological site of care (or other VA special-
ist if no previous neurologic visit) was obtained by post-
encounter interview.
To measure efficiency (goal 1) the neurologist recorded 
the duration of the encounter and exam at each visit.
To measure PN guideline-concordant care (goal 2) we 
recorded the medical decision making plan (e.g., tests, refer-
rals, or treatments) from the health record and verified how 
often the neurologist completed three quality indicators: 
ordering all high-yield PN laboratory tests (any diabetes test, 
B12, SPEP) since the onset of PN symptoms [3]; reducing 
or eliminating opiate use for chronic non-cancer pain [23]; 
and ordering PT for patients with falls or near-falls in the last 
year [4, 24]. We selected this subset of guideline-concordant 
quality indicators based on institutional priorities and stake-
holder feedback.
To measure patient satisfaction (goal 3) the study author 
conducted a short, verbal satisfaction survey (see Appendix) 
within 24 h after the appointment. In the survey, patients 
were asked about their satisfaction with the encounter using 
Likert scales (1–10 for overall score and 1–5 for component 
scores of vitals/check-in, exam, and history), their preference 
for follow-up visit location (a five-item ordinal rank from 
strong preference for usual in-person care at neurological 
site to strong preference for tele-PN care at local CBOC), 
and their feedback on what they liked most and least about 
the visit.
Analysis
We provide summary statistics on key operational metrics 
of the tele-PN clinic: visit show-rate, travel time saved, 
encounter time, and exam time. We performed linear 
regressions of encounter and exam time on CBOC location, 
accounting for encounter type (initial vs. return). We per-
formed Spearman correlations to look at the relationship 
between the pilot encounter number (listed as 1–48) and 
either the encounter time or exam time to look for trends in 
efficiency performance.
For care delivery, we first describe the baseline character-
istics of the 25 patients. We then describe the percentage of 
guideline-concordant care in the tele-PN medical decision 
making plan.
For patient experience, we provide summary statistics for 
component satisfaction scores (i.e., check-in, exam, history), 
overall satisfaction, and clinic preference. We performed 
Spearman correlations to look at the relationship between 
the pilot encounter number (listed as 1–48) and satisfaction 
or clinic preference scores.
We performed a thematic analysis with deductive coding 
on the free response survey feedback from patients and on 
performance improvement memos from the clinical team. 
The 4 a priori codes (convenience, efficiency, symptoms, 
and communication) were based on our key driver dia-
gram for achieving high patient-satisfaction scores (Fig. 2), 
which was informed by Hebert’s telehealth evaluation 
framework [25]. For the qualitative analysis, a subset of 
authors (AMW, NIJ, AH, JAT) started with independent 
coding prior to meeting as a team to discuss, modify, and 
expand the codes. All authors reviewed and refined the 
final codes and themes.
Quantitative analysis was conducted using STATA v15. 
Statistical tests significant at the alpha = 0.05 level are 
listed in the results. Qualitative analysis was performed 
by hand.
Goal:
Be neurology 
clinic of choice to 
>80% of paents 
served  
Convenience of clinic (locaon and me)
Symptom improvement
Good communicaon with provider
Efficient visit
KEY DRIVERS
Fig. 2  Key driver diagram. This diagram illustrates our proposed 
drivers of high-satisfaction scores, and ultimately, being the pre-
ferred clinical choice of patients who may either not receive specialty 
care, receive in-person specialty care at a more distant VA center, or 
receive specialty care outside of the VA system in their local area. 
This driver diagram includes structural factors (convenience of 
clinic), process factors (efficient visit, good communication), and out-
come factors (symptom improvement) that we felt were important to 
measure to evaluate the clinic’s performance
483Journal of Neurology (2020) 267:479–490 
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Results
Tele‑PN operational metrics
As of August 31, 2018, we had a sample of 48 scheduled 
encounters from the first 25 unique individuals. All 25 
patients who were invited to participate in the pilot accepted 
the invitation to be seen in the tele-PN clinic. During the 
pilot phase, the show rate of the tele-PN clinic was 92% (44 
out of 48 encounters). Compared to their usual site of neuro-
logic or specialty care, the tele-PN clinic saved participants 
231 min of round-trip travel per person with an interquar-
tile range (IQR) of 150–280 min. The average encounter 
time (history, exam, and documentation) was 28.5 min (IQR 
of 22–32 min). The average exam time was 9.1 min (IQR 
of 8–10 min). Total encounter time was 8.8 min longer for 
initial than for return encounters (P value < 0.001). Total 
exam time was similar for initial and return exams. The pilot 
sites did not differ in their average encounter times or exam 
times. Total encounter time did not change over the study 
period, although exam duration declined over time (Spear-
man rho =  − 0.52; P value < 0.001), suggesting that more of 
the encounter was spent on non-exam activity.
Tele‑PN clinical care
Patient baseline characteristics
All patients were male with an average age of 70 years (SD 
7 years). Six of the 25 patients had not previously been 
referred to VA neurology; 19 had seen a VA neurologist 
before, though 6 had been lost to follow-up. Eleven patients 
were using a mobility-assist device (e.g., cane, walker, or 
scooter). The three most common PN etiologies by medical 
documentation were diabetes/pre-diabetes (n = 11), medica-
tion-related (n = 5), and idiopathic (n = 5).
At baseline, complete high-yield lab testing (all three 
tests) had been performed for 20 patients since symptom 
onset. Eight patients were being chronically treated with 
short-acting opiates. Twelve patients had experienced falls 
in the last year, seven of whom had undergone physical 
therapy.
Quality indicators and updated plan of care
After their first tele-PN visit, the remaining five patients had 
the high-yield lab tests performed, bringing the percentage 
of patients receiving the entire high-yield set to 100%. Opi-
ates were eliminated in 5 of 8 instances. Eighteen patients 
had consults placed for physical therapy for either balance/
gait training (n = 13) or evaluation of a mobility-assist device 
(n = 5). All patients with recent falls were referred to physi-
cal therapy. The quality indicator performance is summa-
rized in Table 2. Additional diagnostic and management 
changes are listed in the appendix.
Tele‑PN patient experience
Figure 3 summarizes the encounter-level, patient experience 
response for the check-in process, exam, and history. The 
average patient-satisfaction score (rated 1–10) of the clinic 
was 8.9 with an IQR of 8–10. When asked their preference 
Table 2  Guideline-concordant 
care indicators of the tele-PN 
pilot cohort
The table highlights the performance on the three guideline-concordant care indicators of the tele-PN 
cohort at the time of their first visit and at the conclusion of the tele-PN pilot evaluation
PN polyneuropathy
a High-yield lab testing was evaluated after the first visit, rather than at the end of the pilot evaluation period
Quality indicator Baseline performance Post-pilot performance
All 3 high-yield PN tests  completeda 80% (20/25) 100% (25/25)
Opiate freedom 68% (17/25) 88% (22/25)
Physical therapy in those with falls 58% (7/12) 100% (16/16)
0 5 10 15 20 25 30 35 40 45 50
Check-In/Vitals
Exam
History
Excellent Good Fair
Fig. 3  Patient satisfaction ratings by encounter component. For each 
encounter (n = 44), patients were asked to rate the check-in process, 
exam, and history on a 5-item scale from excellent to very poor. For 
the check-in process, there were 34 excellent, 7 good, and 3 fair rat-
ings. For the exam, there were 33 excellent, 10 good, and 1 fair rat-
ings. For the history, there were 34 excellent, 9 good, and 1 fair rat-
ings. No respondents answered poor or very poor
484 Journal of Neurology (2020) 267:479–490
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of location for their future neurology visit, patients “strongly 
preferred” the tele-PN clinic 75% of the time (n = 33 encoun-
ters) and “slightly preferred” the tele-PN clinic 11% of the 
time (n = 5 encounters). No patient slightly or strongly pre-
ferred in-person care for follow-up. There was a significant 
Spearman correlation between the later chronological pilot 
encounter number and a more favorable ordinal follow-up 
preference rank (rho = 0.48; P value < 0.001). There was no 
significant Spearman correlation between the pilot encoun-
ter number and the overall satisfaction score or component 
satisfaction scores.
Tele‑PN qualitative feedback
Table 3 summarizes the themes and representative quotes 
that emerged from our content analysis of patients’ post-
visit feedback and the clinical team’s monthly internal per-
formance memos. As expected, the first theme focused on 
the convenient location of the clinic, which was frequently 
and favorably mentioned by patients. While the travel time 
reduction was substantial for all, we noticed that for some 
patients the convenience of tele-PN was simply a perk, while 
for others, it was a decisive factor in accessing neurologic 
care. This was especially true for patients with limited driv-
ing secondary to their medical conditions. The study team 
hypothesized that the limited time offering of the clinic 
would be a detraction, but patients were already accustomed 
to forgoing an entire day to be seen in a specialty clinic. 
Team memos do not reflect any challenges related to clinic 
timing. 
Another theme surrounded the interpersonal relationship 
between the patient and the care team. While some com-
ments addressed the professionalism of the medical team, 
many comments revealed an affinity for the personality of 
the clinic. The memos reflect that Veterans perceived the 
tele-PN visits had a more casual and collaborative atmos-
phere. There were a similar number of comments about the 
neurologist and the telepresenter, highlighting an important 
contribution of the telepresenters beyond physical exam 
technicians. Despite the praise of the patient-care team rela-
tionship, many patients did ask if we were ever going to have 
an in-person clinic at the community site. We interpreted 
this to mean that the digital touch might not be an exact 
substitute for in-person contact with a specialist.
The third theme highlights the two distinct paradigms that 
patients used to rate the clinic. One set of patients focused on 
Table 3  Qualitative themes and 
representative quotes
Theme 1:  Convenience can be a perk or a necessity for care
Codes: convenience, access, travel
• “[The tele-PN clinic] is very convenient, and I don’t have to drive into the busy Los 
Angeles area.”  
• “Normally I would have to drive the night before and stay at a motel.  What’s worse, I 
might not take my medicines because they make driving more difficult.”  
• “I can’t leave my wife home alone for the day.  She has Alzheimer’s Dementia,” 
• “I won’t go to [the Los Angeles VA hospital] for care.  It is too stressful and confusing.”
Theme 2:  A digital touch can be healing but is not a pure substitute for in-person contact
Codes: communication, relationship
• “It was a very good interaction.  I like the banter of this clinic.”
• “I feel like part of the team and that they actually want to fix the problem.”  
• “[The telepresenter] is very helpful because he knows my medicines.”
• “I like coming to the [local community] clinic because I know the people.”  
• “I like the personal touch [of in-person care.]  Do you guys come out here for clinic?”
Theme 3:  Satisfaction scores sensitive to point of reference: clinic logistics vs. treatment 
outcomes  
Codes: efficiency, symptoms, expectations
• “This is exactly like the in-person [neurology] clinic.  You do the same thing.  You ask the 
same questions and do the same exam.”  
• “The clinic is [on-time] and efficient.  I don’t sit in the waiting room all day.” 
• “Two thumbs up.  This is one of the best VA clinics.  It is very thorough.”
• “There was confusion at the [front desk], and they sent me to the upstairs waiting room.”
• “I wish you could stop the pain, but I know there is nothing you can do about that.”
Theme 4:  Environmental factors negatively impact the clinics’ utility
Codes: space, audio, visual, equipment
• “It didn’t seem like the doctor could see my walking.”  
• “It was hard to do the exam properly because I could not hear the doctor.”
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the mechanics of the tele-PN clinic and how it compared to 
other in-person clinics. Overall, this group was pleased with 
the efficiency of the clinic, with some variation in how the 
remote exam compared to in-person exams (a more struc-
tured and detailed exam versus exactly the same exam versus 
a simplified and abbreviated exam). The other set of patients 
focused on the clinical outcome of the visit. Patients who did 
not have substantive changes to the care plan, or who did not 
anticipate the changes to result in PN symptom improve-
ment, provided more modest satisfaction scores.
Finally, the fourth theme focused on the environmental 
challenges to the tele-PN clinic, specifically the clinical 
space and technical aspects of the tele-PN encounter. In gen-
eral, there were no unanticipated audiovisual issues. Patients 
with hearing loss did require more frequent repetition of 
questions and directions, which slightly reduced satisfac-
tion scores. At two sites, the telemedicine room is small and 
requires additional maneuvering of the examination chair to 
complete the exam. This challenge was noted only once by a 
patient, whereas the team memos demonstrate considerable 
effort to conduct a more precise staging of the VANS exam 
within the room and a higher skill of camera steering to 
observe exam features. The smaller room was perceived to 
slow down the exam and potentially alienate patients, though 
not necessarily change the VANS score.
Discussion
This study represents the first teleneurology pilot specifi-
cally designed for PN care. Over the course of 1 year, we 
were able to open and evaluate tele-PN clinics at three dif-
ferent CBOCs within the Greater Los Angeles VA region. 
We learned that these teleneurology clinics could be suc-
cessfully incorporated into the larger healthcare ecosystem 
with a unique patient screening function to optimize the 
clinical utility of the clinic. At the initial visit, all patients 
were judged to have PN, and none were found to be inap-
propriate for the clinic. Further, we demonstrated at each 
spoke that the tele-PN care team (neurologist and telep-
resenter dyad) can see patients at least as efficiently as a 
normal in-person encounter. In fact, there is a suggestion 
from our timed encounters (nearly ¾ of which last less than 
30 min) and patient feedback that our tele-PN visits are 
quicker than our in-person encounters, with a reduction in 
non-productive waiting time. This efficiency gain was not 
at the expense of desirable consultation time, which was 
praised as “thorough” and imperative for building a strong 
patient–doctor relationship. We also noted a lower no-show 
rate of 8% in the tele-PN clinics compared to 10–15% for 
our in-person clinic (personal communication with clinic 
manager), despite using the same appointment reminders 
as our in-person clinic. Whether this was related to a small 
sample size, the novelty and convenience of the clinic, or 
another factor is not known.
Similar to previous outpatient teleneurology studies 
[26–28], our pilot consistently received excellent satisfac-
tion scores. Patients preferred to follow-up in the tele-PN 
clinic over our closest in-person neurology clinic 86% of 
the time, with the remaining 14% having no preference. 
As expected, convenience was a big driver of its favorabil-
ity, saving an average travel time of 231 min per patient; 
however, we also explicitly asked about the encounter com-
ponents, and the check-in process, exam, and history were 
each rated as “very good” or “excellent” about 95% of the 
time. In particular, patients appreciated “smooth” transitions 
and the personal touch of the tele-PN clinic. The theme of 
strong interpersonal engagement as a marker of quality in 
teleneurology has been noted elsewhere [29]. Of import, 
the care team memos also reflect a joy for this team-based 
care and the diversity it brings to their other clinical tasks. 
Concerns with the telemedicine technology were largely 
absent from patient feedback and provider memos, though 
it appears patients who are hard of hearing may be suscep-
tible to a subpar experience. We speculate that the remote 
encounter may slightly distort the audio and make it more 
difficult to lip-read. Interestingly, while smaller telemedicine 
rooms were felt to hinder the VANS exam by the provider 
team, longer exam times or lower satisfaction scores were 
not found in the pilot.
Importantly, our tele-PN clinic was able to improve the 
care of patients with moderate-to-severe PN (mild PN was 
not well represented in the pilot). This cohort had many risk 
factors for deterioration including advanced age, polyphar-
macy, falls, and the need for mobility-assist devices. In only 
three cases did the neurologist not order additional diagnos-
tic tests, make a referral, or adjust medications. In all other 
cases, there was at least one shared-decision management 
change. In terms of guideline-concordant care for the cohort, 
high-yield labs were ordered for five patients (leading to two 
new diagnoses and a 100% compliance rate for lab testing), 
timely referrals to physical therapy were made for all 16 
patients with falls, and opiates were successfully reduced or 
replaced with preferred neuropathic pain medicines in five of 
eight patients. Beyond these pre-specified indicators, there 
were numerous other instances of improved pain control 
with more aggressive treatment. While most patients did see 
improvement in their symptoms, the continued existence of 
this chronic condition did leave some requesting even more 
radical therapies (e.g., amputation, stem cells).
Given the disparity between the short supply of neu-
rologists, especially in rural areas, and the high prevalence 
of PN, teleneurology clinics tailored for PN could bridge 
this gap in access to care. The hub-and-spoke model of our 
telemedicine pilot study is well suited to enabling a spe-
cialist in an urban setting to evaluate and manage patients 
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with common disorders who live in remote or medically 
underserved regions. Future investigations could explore the 
feasibility of large-scale tele-PN clinics and their ability to 
improve neurological care in the setting of a limited work-
force of neurologists.
Limitations
As a telemedicine pilot study expanding to a new condition, 
this work has some expected limitations. We present rich 
clinical data on a small sample of 25 patients without a clini-
cal control. The patient selection was not random, but driven 
by geographic and clinical factors. We believe these patients 
to be practical and informative “real-world” test cases for 
tele-PN. The fact that a large majority of our sample had 
seen neurology in-person before is typical of our health 
system, and likely diminishes the impact the tele-PN clinic 
would have on guideline-concordant care in neurology-naïve 
or de novo cases. The scope of this work is also limited—we 
do not address clinical outcomes (including patient-reported 
outcomes), healthcare utilization, or costs. We hope to evalu-
ate these factors in future quasi-experimental and experi-
mental approaches.
The tele-PN clinic has important contextual features that 
impact its generalizability. The VA-integrated health sys-
tem has unique financial and health care delivery structures 
that support telemedicine. Accessible medical records and 
existing telemedicine equipment and personnel were essen-
tial to the successful screening and management of patients 
with PN for this pilot. Healthcare systems without these 
features may not be able to replicate tele-PN clinics in the 
same fashion as we present here. Also, as currently con-
structed, the tele-PN clinics do not impact individuals in our 
health system who may have signs or symptoms of PN, but 
do not carry the diagnosis in the electronic health record. 
Additional studies of how telehealth initiatives, including 
telemedicine, fit into a larger evidence-based practice envi-
ronment is still warranted.
Finally, we (AMW, NIJ, AH) acknowledge our own 
potential biases to act as both clinicians and research-
ers in this evaluation. Where possible, we have created 
independent review of tasks requiring clinical judgement, 
and we openly discuss our findings with the entire research 
team in pursuit of a fair and informative evaluation of this 
pilot study.
Conclusion
In conclusion, we show that teleneurology for polyneuropa-
thy is feasible in the setting of thoughtful patient screening 
and remote neurologic examination. Based on our mixed-
methods pilot evaluation, tele-PN clinics demonstrate 
promise as a promoter of evidence-based practice and a 
patient-preferred mode of care. Given this feasibility and 
acceptability, future studies should focus on demonstrating 
their efficacy in improving the patient experience, improving 
health outcomes, and reducing costs compared to the stand-
ard of care. We hope this work will stimulate more consid-
eration of how teleneurology can be utilized to improve the 
care pathway for patients with neurologic disorders.
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Appendix 1
Post Visit Survey
- - - - - first encounter only - - - - -
1) ON AVERAGE, how long does it take to travel ROUND TRIP to and from your residence to the local VA 
clinic?  (Only include your travel me; do not include the me spent at the clinic)
2a) If you see or have seen a neurologist in-person through the VA, what site do you usually go?
[  ] Sepulveda        [  ] West LA VA        [  ] LA Ambulatory Care Center (downtown)
[  ] Other ___________________________
[  ] I have not seen a neurologist through the VA, skip to queson 3a
2b) If you see or have seen a neurologist in-person through the VA: ON AVERAGE, how long does it take 
to travel ROUND TRIP to and from your residence to the locaon you selected in queson #2a? (Only 
include your travel me; do not include the me spent at the clinic/hospital)
3a) If you see or have seen a specialist in-person through the VA, what site do you usually go?
[  ] Sepulveda        [  ] West LA VA        [  ] LA Ambulatory Care Center (downtown)
[  ] Other ___________________________
[  ] I have not seen a specialist through the VA, skip to queson 4a
3b) If you see or have seen a specialist in-person through the VA: ON AVERAGE, how long does it take to 
travel ROUND TRIP to and from your residence to the locaon you selected in queson #3a? (Only 
include your travel me; do not include the me spent at the clinic/hospital)
4a) Do you see a neurologist outside the VA system, such as through the CHOICE program?
[  ] YES        [  ] NO, skip to queson 5
4b) If you see a neurologist in-person outside the VA system: ON AVERAGE, how long does it take to 
travel ROUND TRIP to and from your residence to that locaon in queson #4a? (Only include your 
travel me; do not include the me spent at the clinic/hospital)
- - - - - all encounters - - - - -
Please answer the following quesons #5-7 using this scale 
1=Very Negave
2=Slightly Negave
3=Neither Posive or Negave
4=Slightly Posive
5=Very Posive
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5) How was the check-in and vitals process (1-5)?
Any comment?
6) How was the physical exam process (1-5)?
Any comment?
7) How was the history / interview process (1-5)?
Any comment?
8) Using a 10-point scale (1 is the worst and 10 is the best), how sa sfied were you with your visit today?
9) Comment on the 1-2 thing(s) you most liked about your visit today
10) Comment on the 1-2 thing(s) you most disliked about your visit today
11) What is your preference for follow-up neurologic care? 
[  ]  I strongly prefer my other source of care
[  ]  I slightly prefer my other source of care
[ ]  I have no preference
[  ]  I slightly prefer the tele-neurology clinic
[  ]  I strongly prefer the tele-neurology clinic
OR This ques on does not apply to me or I cannot judge [  ]
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See Appendix Table 4.
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